Schrödinger, Inc. (SDGR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Schrödinger, Inc. (SDGR)
Go deeper and ask any question about SDGR
Company Performance
Current Price
as of Sep 13, 2024$20.73
P/E Ratio
N/A
Market Cap
$1.32B
Description
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Metrics
Overview
- HQNew York, NY
- SectorTechnology Services
- IndustryPackaged Software
- TickerSDGR
- Price$20.73+0.68%
Trading Information
- Market Cap$1.32B
- Float85.22%
- Average Daily Volume (1m)517,368
- Average Daily Volume (3m)679,464
- EPS-$2.79
Company
- Revenue$200.63M
- Rev Growth (1yr)34.51%
- Net Income-$54.05M
- Gross Margin66.20%
- EBITDA Margin-108.44%
- EBITDA-$51.33M
- EV$1.15B
- EV/Revenue5.73
- P/EN/A
- P/S7.51